Malihe Hassanzadeh
Sherbrooke, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Tunable Biased Signaling of the Angiotensin II Type 1 Receptor for Inotropy via C-Terminal Peptide Engineering and Allosteric Site Targeting.
Journal: Journal of medicinal chemistry
Published: January 16, 2026
Structural insights into frog skin-derived cyclic peptides as selective matriptase inhibitors.
Journal: European journal of medicinal chemistry
Published: August 30, 2025
A neurotensin receptor type 1-derived pepducin acts as a biased allosteric modulator to regulate target receptor function.
Journal: Acta pharmaceutica Sinica. B
Published: August 01, 2025
From N-0385 to N-0920: Unveiling a Host-Directed Protease Inhibitor with Picomolar Antiviral Efficacy against Prevalent SARS-CoV-2 Variants.
Journal: Journal of medicinal chemistry
Published: March 31, 2025
Development of ketobenzothiazole-based peptidomimetic TMPRSS13 inhibitors with low nanomolar potency.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: February 20, 2025
Development of ketobenzothiazole-based peptidomimetic TMPRSS13 inhibitors with low nanomolar potency.
Journal: bioRxiv : the preprint server for biology
Published: September 11, 2024
Optimization of Ketobenzothiazole-Based Type II Transmembrane Serine Protease Inhibitors to Block H1N1 Influenza Virus Replication.
Journal: ChemMedChem
Published: August 23, 2023
Editorial: Hot trends in computer-aided drug design techniques.
Journal: Frontiers in cellular and infection microbiology
Published: January 23, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026